Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00501007 · ClinicalTrials.gov registry record
Predictors of Treatment Outcome for Smokers With and Without Schizophrenia
A clinical trial, sponsored by Rutgers, The State University of New Jersey.
- Completed
- Registry status
- 203
- Enrollment target
NCT00501007 is a clinical trial that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 203 participants.
The verdict
NCT00501007 has completed, sponsored by Rutgers, The State University of New Jersey.
- COMPLETED
- Registry status
- 203 participants
- Enrollment target
Study Summary
The primary purpose of this investigation is to determine the predictive value of task persistence as measured by a mirror tracing task. A secondary purpose is to evaluate differences in task persistence in smokers with or without schizophrenia. It is hypothesized that task persistence in smokers in both diagnostic categories (schizophrenia and no schizophrenia) will predict tobacco dependence treatment outcome at one and six months. It is also hypothesized that smokers with schizophrenia will show lower levels of task persistence after controlling for other motor skills than smokers without schizophrenia.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 203 participants |
| Start Date | 2005-02 |
| Est. Completion | 2013-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00501007
The ClinicalTrials.gov registry entry for NCT00501007 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 203 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00501007 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00501007 about?
NCT00501007 is a clinical study titled "Predictors of Treatment Outcome for Smokers With and Without Schizophrenia". The primary purpose of this investigation is to determine the predictive value of task persistence as measured by a mirror tracing task. A secondary purpose is to evaluate differences in task persistence in smokers with or without schizophrenia. It is hypothesized that task persistence in smokers in...
What is the current status of trial NCT00501007?
This trial is currently completed. The enrollment target is 203 participants. The study started on 2005-02. Estimated completion is 2013-01.
Who is sponsoring clinical trial NCT00501007?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.